References
- Henriksen NA, Deerenberg EB, Venclauskas L, et al. Meta-analysis on materials and techniques for laparotomy closure: the match review. World J Surg. 2018;42:1666–1678.
- Bosanquet DC, Ansell J, Abdelrahman T, et al. Systematic review and meta-regression of factors affecting midline incisional hernia rates: analysis of 14,618 patients. PLoS ONE. 2015;10:e0138745.
- Pogacnik JS, Messaris E, Deiling SM, et al. Increased risk of incisional hernia after sigmoid colectomy for diverticulitis compared with colon cancer. J Am Coll Surg. 2014;218:920–928.
- Poulose BK, Shelton J, Phillips S, et al. Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia. 2012;16:179–183.
- Read RC, Yoder G. Recent trends in the management of incisional herniation. Arch Surg. 1989;124:485–488.
- Kingsnorth A. The management of incisional hernia. Ann R Coll Surg Engl. 2006;88:252–260.
- Casanova AB, Trindade EN, Trindade MRM. Collagen in the transversalis fascia of patients with indirect inguinal hernia: a case-control study. Am J Surg. 2009;198:1–5.
- Klinge U, Si ZY, Zheng H, et al. Collagen I/III and matrix metalloproteinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg. 2001;14:47–54.
- Klinge U, Zheng H, Si ZY, et al. Synthesis of type I and III collagen, expression of fibronectin and matrix metalloproteinases-1 and −13 in hernial sac of patients with inguinal hernia. Int J Surg Investig. 1999;1:219–227.
- Klinge U, Zheng H, Si Z, et al. Expression of the extracellular matrix proteins collagen I, collagen III and fibronectin and matrix metalloproteinase-1 and −13 in the skin of patients with inguinal hernia. Eur Surg Res. 1999;31:480–490.
- Rosch R, Junge K, Knops M, et al. Analysis of collagen-interacting proteins in patients with incisional hernias. Langenbecks Arch Surg. 2003;387:427–432.
- Salameh JR, Talbott LM, May W, et al. Role of biomarkers in incisional hernias. Am Surg. 2007;73:561–567; discussion 567-568.
- Karsdal MA, Nielsen MJ, Sand JM, et al. Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol. 2013;11:70–92.
- Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol. 2014;62:91–95.
- Gonzalez ACDO, Costa TF, Andrade ZDA, et al. Wound healing - A literature review. An Bras Dermatol. 2016;91:614–620.
- Medrado ARAP, Pugliese LS, Reis SRA, et al. Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts. Lasers Surg Med. 2003;32:239–244.
- Rodero MP, Khosrotehrani K. Skin wound healing modulation by macrophages. Int J Clin Exp Pathol. 2010;3:643–653.
- Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127:514–525.
- Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738–746.
- Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol. 2007;25:9–18.
- Medrado A, Costa T, Prado T, et al. Phenotype characterization of pericytes during tissue repair following low-level laser therapy. Photodermatol Photoimmunol Photomed. 2010;26:192–197.
- Schilling JA. Wound healing. Surg Clin North Am. 1976;56:859–874.
- Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol. 2002;13:377–383.
- Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004;36:1031–1037.
- Antoniou GA, Georgiadis GS, Antoniou SA, et al. Abdominal aortic aneurysm and abdominal wall hernia as manifestations of a connective tissue disorder. J Vasc Surg. 2011;54:1175–1181.
- Holihan JL, Alawadi Z, Martindale RG, et al. Adverse events after ventral hernia repair: the vicious cycle of complications. J Am Coll Surg. 2015;221:478–485.
- Radu P, Brãtucu M, Garofil D, et al. The role of collagen metabolism in the formation and relapse of incisional hernia. Chirurgia (Bucur). 2015 May-Jun;110(3):224–230.
- Henriksen NA, Yadete DH, Sorensen LT, et al. Connective tissue alteration in abdominal wall hernia. Br J Surg. 2011;98:210–219.
- Antoniou SA, Antoniou GA, Granderath FA, et al. The role of matrix metalloproteinases in the pathogenesis of abdominal wall hernias. Eur J Clin Invest. 2009;39:953–959.
- Elkington PT, Green JA, Friedland JS. Analysis of matrix metalloproteinase secretion by macrophages. Methods Mol Biol. 2009;531:253–265.
- Kanangat S, Postlethwaite A, Hasty K, et al. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther. 2006;8:R176.
- White B, Osier C, Gletsu N, et al. Abnormal primary tissue collagen composition in the skin of recurrent incisional hernia patients. Am Surg. 2007;73:1254–1258.
- Nissinen L, Kähäri V-M. Matrix metalloproteinases in inflammation. Biochim Biophys Acta. 2014;1840:2571–2580.
- Henriksen NA. Systemic and local collagen turnover in hernia patients. Dan Med J. 2016 Jul;63(7). pii: B5265. PMID:27399987.
- Lorentzen L, Henriksen NA, Juhl P, et al. Type V collagen is persistently altered after inguinal hernia repair. Scand J Surg. 2018 Sep;107(3):212–217. doi: 10.1177/1457496918766694. PMID:29628013.
- Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11:529–543.
- Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52–67.
- Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463–516.
- Toriseva M, Kähäri V-M. Proteinases in cutaneous wound healing. Cell Mol Life Sci. 2009;66:203–224.
- Bellón JM, Buján J, Honduvilla NG, et al. Study of biochemical substrate and role of metalloproteinases in fascia transversalis from hernial processes. Eur J Clin Invest. 1997;27:510–516.
- Antoniou GA, Tentes IK, Antoniou SA, et al. Matrix metalloproteinase imbalance in inguinal hernia formation. J Invest Surg. 2011;24:145–150.
- Rosch R, Lynen-Jansen P, Junge K, et al. Biomaterial-dependent MMP-2 expression in fibroblasts from patients with recurrent incisional hernias. Hernia. 2006;10:125–130.
- Rosch R, Klinge U, Si Z, et al. A role for the collagen I/III and MMP-1/-13 genes in primary inguinal hernia? BMC Med. Genet. 2002;3:2.
- Zheng ZS, Reiner Kasperk H. Recurrent inguinal hernia: disease of the collagen matrix? World J Surg. 2002;26:401–408.
- Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494.
- Serra R, Buffone G, Costanzo G, et al. Altered metalloproteinase-9 expression as least common denominator between varicocele, inguinal hernia, and chronic venous disorders. Ann Vasc Surg. 2014;28:705–709.
- Bellón JM, Bajo A, Ga-Honduvilla N, et al. Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg. 2001;233:287–291.
- Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010;1803:55–71.
- Guillen-Marti J, Diaz R, Quiles MT, et al. MMPs/TIMPs and inflammatory signalling de-regulation in human incisional hernia tissues. J Cell Mol Med. 2009;13:4432–4443.
- Henriksen NA, Sørensen LT, Jorgensen LN, et al. Circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with incisional hernia: MMP and TIMP in incisional hernia patients. Wound Repair Regener. 2013;21:661–666.
- Pandolfi F, Altamura S, Frosali S, et al. Key role of DAMP in inflammation, cancer, and tissue repair. Clin Ther. 2016;38:1017–1028.
- Magna M, Pisetsky DS. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med. 2014;20:138–146.
- Thankam FG, Dilisio MF, Dietz NE, et al. TREM-1, HMGB1 and RAGE in the shoulder tendon: dual mechanisms for inflammation based on the coincidence of glenohumeral arthritis. Abraham T, editor. PLOS ONE. 2016;11:e0165492.
- Thankam FG, Roesch ZK, Dilisio MF, et al. Association of inflammatory responses and ECM disorganization with HMGB1 upregulation and NLRP3 inflammasome activation in the injured rotator cuff tendon. Sci Rep [Internet]. 2018 [cited 2018 Jun 19];8. Available from: http://www.nature.com/articles/s41598-018-27250-2
- Cheng Y, Wang D, Wang B, et al. HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway. Mol Biol Cell. 2017;28:201–209.
- Wang X, Xiang L, Li H, et al. The role of HMGB1 signaling pathway in the development and progression of hepatocellular carcinoma: a review. Int J Mol Sci. 2015;16:22527–22540.
- Schaefer L, Babelova A, Kiss E, et al. The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages. J Clin Invest. 2005;115:2223–2233.
- Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol [Internet]. 2014 [cited 2018 Jun 19];5. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2014.00461/abstract
- Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.
- Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373–384.
- El Mezayen R, El Gazzar M, Seeds MC, et al. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett. 2007;111:36–44.
- Mohamadzadeh M, Coberley SS, Olinger GG, et al. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses. J Virol. 2006;80:7235–7244.
- Molloy EJ. Triggering receptor expressed on myeloid cells (TREM) family and the application of its antagonists. Recent Pat Antiinfect Drug Discov. 2009;4:51–56.
- Rao VH, Rai V, Stoupa S, et al. Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis. Atherosclerosis. 2016;248:160–169.
- Thankam FG, Dilisio MF, Dougherty KA, et al. Triggering receptor expressed on myeloid cells and 5ʹadenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target. Expert Rev Clin Immunol. 2016;12:1239–1249.
- Haselmayer P, Grosse-Hovest L, von Landenberg P, et al. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood. 2007;110:1029–1035.
- Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991–4995.
- Hu L, Du Z, Zhao G, et al. Role of TREM-1 in response to aspergillus fumigatus infection in corneal epithelial cells. Int Immunopharmacol. 2014;23:288–293.
- Ornatowska M, Azim AC, Wang X, et al. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1377–1384.
- Zhang S-Y, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317:1522–1527.
- Sims GP, Rowe DC, Rietdijk ST, et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 2010;28:367–388.
- Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97:889–901.
- Huttunen HJ, Kuja-Panula J, Sorci G, et al. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem. 2000;275:40096–40105.
- Palumbo R, De Marchis F, Pusterla T, et al. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J Leukoc Biol. 2009;86:617–623.
- Bassi R, Giussani P, Anelli V, et al. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J Neurooncol. 2008;87:23–33.
- Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W, et al. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J Neurochem. 2003;87:44–55.
- Touré F, Zahm J-M, Garnotel R, et al. Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J. 2008;416:255–261.
- Hudson BI, Kalea AZ, Del Mar Arriero M, et al. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem. 2008;283:34457–34468.
- Kim JY, Park HK, Yoon JS, et al. Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways. Int J Oncol. 2008;33:493–501.
- Reddy MA, Li S-L, Sahar S, et al. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem. 2006;281:13685–13693.
- Taguchi A, Blood DC, Del Toro G, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000;405:354–360.
- Chi W, Chen H, Li F, et al. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation. 2015;12:137.
- Jo E-K, Kim JK, Shin D-M, et al. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148–159.
- Lu B, Nakamura T, Inouye K, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012;488:670–674.
- Cox SW, Eley BM, Kiili M, et al. Collagen degradation by interleukin-1beta-stimulated gingival fibroblasts is accompanied by release and activation of multiple matrix metalloproteinases and cysteine proteinases. Oral Dis. 2006;12:34–40.
- Xie J, Fu N, Cai L-Y, et al. The effects of interleukin-1β in modulating osteoclast-conditioned medium’s influence on gelatinases in chondrocytes through mitogen-activated protein kinases. Int J Oral Sci. 2015;7:220–231.
- Bezerra FS, Valença SS, Pires KMP, et al. Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice. Respir Physiol Neurobiol. 2011;177:120–126.
- Yu Y, Yang L, Lv J, et al. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis. Int J Clin Exp Pathol. 2015;8:6807–6813.